Search alternatives:
ann decrease » nn decrease (Expand Search), gain decreased (Expand Search), mean decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
d decrease » _ decreased (Expand Search), _ decreases (Expand Search), a decreased (Expand Search)
_ ann » _ any (Expand Search), _ ant (Expand Search), _ anc (Expand Search)
ann decrease » nn decrease (Expand Search), gain decreased (Expand Search), mean decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
d decrease » _ decreased (Expand Search), _ decreases (Expand Search), a decreased (Expand Search)
_ ann » _ any (Expand Search), _ ant (Expand Search), _ anc (Expand Search)
-
1
-
2
-
3
WNT3 decreases GCP proliferation by inhibiting SHH dependent gene transcription.
Published 2013“…(<i>D</i>) WNT3 decreased Gli1, and <i>Ptch1</i> mRNA levels after 6 h of treatment (Con=1; WNT3: Gli1=0.56±0.10, Gli2=0.90±0.10, Mycn= 0.99±0.05, <i>Ptch1</i>=0.58±0.09, and <i>Ccnd1</i>=0.89±0.09). …”
-
4
-
5
-
6
-
7
-
8
-
9
CC-1<sup>+</sup> immunostained cell numbers decrease by 2 days after TBI and return to control levels by 5 weeks.
Published 2015“…Panels show contralateral (Contra) and ipsilateral (Ipsi) external capsule (EC) at (A,B) 2 days (2d), (C,D) 2 weeks (2w) and (E,F) 5 weeks (5w) (G) In the external capsule numbers of CC-1<sup>+</sup> oligodendrocytes were decreased by 2d after injury, remained decreased at 2 weeks and returned to normal levels by 5 weeks. …”
-
10
-
11
-
12
HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching.
Published 2015“…<p><b>A,B:</b> Gene knockdown of EZH2 and SUZ12 was confirmed by qPCR. <b>C,D:</b> In HRMECs transfected with EZH2 siRNA in HG, miR-200b and VEGF were not significantly different from HG+control siRNA but decreased compared to NG+control siRNA. …”
-
13
-
14
-
15
-
16
-
17
-
18
-
19
Decrease of myopia progression with 0.025% atropine
Published 2018“…Myopic progression was significantly lower in group 1 (-0.43 +/- 0.19 D) than in group 2 (-1.24 +/- 0.37 D) and axial length increase was also significantly smaller in group 1(0.19 +/- 0.09 mm) than in group 2 (0.48 +/- 0.12 mm). …”
-
20